Sheila Singh
Overview
Explore the profile of Sheila Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
691
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delaidelli A, Burwag F, Ben-Neriah S, Suk Y, Shyp T, Kosteniuk S, et al.
Neuro Oncol
. 2025 Mar;
PMID: 40040502
Background: While international consensus and the 2021 WHO classification recognize multiple molecular medulloblastoma subgroups, these are difficult to identify in clinical practice utilizing routine approaches. As a result, biology-driven risk...
2.
Mikolajewicz N, Tatari N, Wei J, Savage N, Farias A, Dimitrov V, et al.
Acta Neuropathol
. 2024 Nov;
148(1):74.
PMID: 39592459
Cancer-intrinsic immune evasion mechanisms and pleiotropy are a barrier to cancer immunotherapy. This is apparent in certain highly fatal cancers, including high-grade gliomas and glioblastomas (GBM). In this study, we...
3.
Seyfrid M, Maich W, Shaikh V, Tatari N, Upreti D, Piyasena D, et al.
J Immunother Cancer
. 2022 Jan;
10(1).
PMID: 35017149
Purpose: Glioblastoma (GBM) patients suffer from a dismal prognosis, with standard of care therapy inevitably leading to therapy-resistant recurrent tumors. The presence of cancer stem cells (CSCs) drives the extensive...
4.
Takroni R, Zagzoog N, Patel N, Martyniuk A, Singh S, Farrokhyar F, et al.
J Neurol Surg A Cent Eur Neurosurg
. 2021 Nov;
84(2):157-166.
PMID: 34784622
Background: Chronic subdural hematoma (CSDH) is a common type of intracranial hemorrhage, especially among the elderly, with a recurrence rate as high as 33%. Little is known about the best...
5.
Brakel B, Chokshi C, Salim S, Venugopal C, Singh S
STAR Protoc
. 2021 Nov;
2(4):100920.
PMID: 34761232
Advances in chimeric antigen receptor (CAR) T cell therapies have led to the modality dominating translational cancer research; however, a standardized protocol for evaluating such therapies is needed. This protocol...
6.
Sogut M, Venugopal C, Kandemir B, Dag U, Mahendram S, Singh S, et al.
J Pers Med
. 2021 Mar;
11(2).
PMID: 33672811
Elk-1, a member of the ternary complex factors (TCFs) within the ETS (E26 transformation-specific) domain superfamily, is a transcription factor implicated in neuroprotection, neurodegeneration, and brain tumor proliferation. Except for...
7.
Tatari N, Maich W, Salim S, McKenna D, Venugopal C, Singh S
STAR Protoc
. 2020 Dec;
1(3):100174.
PMID: 33377068
Glioblastoma (GBM) is the most common malignant adult brain tumor that is resistant to the standard care therapy. Advances in chimeric antigen receptor (CAR) T cell therapies have spurred renewed...
8.
Vora P, Venugopal C, Salim S, Tatari N, Bakhshinyan D, Singh M, et al.
Cell Stem Cell
. 2020 May;
26(6):832-844.e6.
PMID: 32464096
CD133 marks self-renewing cancer stem cells (CSCs) in a variety of solid tumors, and CD133+ tumor-initiating cells are known markers of chemo- and radio-resistance in multiple aggressive cancers, including glioblastoma...
9.
Michealraj K, Kumar S, Kim L, Cavalli F, Przelicki D, Wojcik J, et al.
Cell
. 2020 May;
181(6):1329-1345.e24.
PMID: 32445698
Posterior fossa A (PFA) ependymomas are lethal malignancies of the hindbrain in infants and toddlers. Lacking highly recurrent somatic mutations, PFA ependymomas are proposed to be epigenetically driven tumors for...
10.
Yang K, Nath S, Koziarz A, Badhiwala J, Ghayur H, Sourour M, et al.
World Neurosurg
. 2018 Sep;
120:e762-e775.
PMID: 30172972
Background: The role of the extent of surgical resection (EOR) in clinical outcomes for patients with low-grade glioma requires further examination. The goal of the present study was to evaluate...